Current and historical daily PE Ratio for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (
SHSE:603392
) from 2020 to May 18 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Beijing Wantai Biological Pharmacy Enterprise stock (SHSE:603392) PE ratio as of May 18 2024 is 666.1.
More Details
Beijing Wantai Biological Pharmacy Enterprise Co Ltd (SHSE:603392) PE Ratio (TTM) Chart
Beijing Wantai Biological Pharmacy Enterprise Co Ltd (SHSE:603392) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 982
- 1
- 2
- 3
- 4
- 5
- 6
- 11
| Beijing Wantai Biological Pharmacy Enterprise PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-18 | 666.1 | 2024-03-11 | 73.4 |
| 2024-05-17 | 666.1 | 2024-03-08 | 73.5 |
| 2024-05-16 | 659.3 | 2024-03-07 | 67.7 |
| 2024-05-15 | 660.3 | 2024-03-06 | 71.7 |
| 2024-05-14 | 672.6 | 2024-03-05 | 74.9 |
| 2024-05-13 | 655.0 | 2024-03-04 | 75.9 |
| 2024-05-10 | 663.0 | 2024-03-01 | 75.8 |
| 2024-05-09 | 683.1 | 2024-02-29 | 74.3 |
| 2024-05-08 | 686.5 | 2024-02-28 | 71.6 |
| 2024-05-07 | 702.3 | 2024-02-27 | 74.8 |
| 2024-05-06 | 692.2 | 2024-02-26 | 68.0 |
| 2024-04-30 | 682.8 | 2024-02-23 | 70.9 |
| 2024-04-29 | 685.0 | 2024-02-22 | 68.0 |
| 2024-04-26 | 682.6 | 2024-02-21 | 61.9 |
| 2024-04-25 | 634.0 | 2024-02-20 | 61.5 |
| 2024-04-24 | 646.4 | 2024-02-19 | 61.3 |
| 2024-04-23 | 660.4 | 2024-02-08 | 63.4 |
| 2024-04-22 | 665.4 | 2024-02-07 | 62.1 |
| 2024-04-19 | 667.2 | 2024-02-06 | 56.4 |
| 2024-04-18 | 672.8 | 2024-02-05 | 51.3 |
| 2024-04-17 | 701.9 | 2024-02-02 | 51.3 |
| 2024-04-16 | 701.3 | 2024-02-01 | 53.5 |
| 2024-04-15 | 713.0 | 2024-01-31 | 54.5 |
| 2024-04-12 | 771.4 | 2024-01-30 | 55.0 |
| 2024-04-11 | 741.6 | 2024-01-29 | 56.6 |
| 2024-04-10 | 674.2 | 2024-01-26 | 61.0 |
| 2024-04-09 | 693.1 | 2024-01-25 | 61.0 |
| 2024-04-08 | 668.5 | 2024-01-24 | 62.6 |
| 2024-04-03 | 642.8 | 2024-01-23 | 65.0 |
| 2024-04-02 | 656.4 | 2024-01-22 | 64.1 |
| 2024-04-01 | 674.0 | 2024-01-19 | 67.9 |
| 2024-03-29 | 676.4 | 2024-01-18 | 69.7 |
| 2024-03-28 | 694.4 | 2024-01-17 | 68.7 |
| 2024-03-27 | 68.8 | 2024-01-16 | 71.6 |
| 2024-03-26 | 71.8 | 2024-01-15 | 74.0 |
| 2024-03-25 | 72.1 | 2024-01-12 | 74.1 |
| 2024-03-22 | 75.8 | 2024-01-11 | 76.5 |
| 2024-03-21 | 75.7 | 2024-01-10 | 77.6 |
| 2024-03-20 | 74.0 | 2024-01-09 | 82.5 |
| 2024-03-19 | 73.7 | 2024-01-08 | 87.9 |
| 2024-03-18 | 74.2 | 2024-01-05 | 81.2 |
| 2024-03-15 | 72.0 | 2024-01-04 | 75.6 |
| 2024-03-14 | 74.2 | 2024-01-03 | 75.8 |
| 2024-03-13 | 73.7 | 2024-01-02 | 78.0 |
| 2024-03-12 | 74.8 | 2023-12-29 | 75.9 |
Beijing Wantai Biological Pharmacy Enterprise Co Ltd (SHSE:603392) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
ISIN : CNE100004090
Share Class Description:
SHSE:603392: Class ACompare
Compare
Traded in other countries / regions
603392.China IPO Date
2020-04-29Description
Beijing Wantai Biological Pharmacy Enterprise Co Ltd is an engaged in the research and development and production of biodiagnostic reagents and vaccines. The company produces chemiluminescence, nucleic acid, clinical biochemistry and other testing reagents and clinical inspection quality control products and vaccines. Its products include ELISA series, Colloidal gold series, Bole series, Confirmation series, Automatic blood group analyzer and reagent, Chemiluminescence series, Nucleic acid series, and Research Series.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers